In this episode, we speak with **Dr. Satabhisa Mukhopadhyay**, Co-Founder and Chief Scientific Officer of 4D Path, about the intersection of physics, AI, and cancer research.
Dr. Mukhopadhyay shares her journey from theoretical physics to cancer systems biology and AI/ML, and discusses how 4D Path’s QPOR™ technology uses computational approaches to transform complex biological data into actionable insights for personalized cancer care.
We also explore clinical trials, predictive diagnostics, regulatory challenges, and the future of AI-driven cancer treatment.
RSS Feed